Cargando…
Drivers of cost differences between US breast cancer survivors with or without lymphedema
PURPOSE: Breast cancer–related lymphedema is an adverse effect of breast cancer surgery affecting nearly 30% of US breast cancer survivors (BCS). Our previous analysis showed that, even 12 years after cancer treatment, out-of-pocket healthcare costs for BCS with lymphedema remained higher than for B...
Autores principales: | Dean, Lorraine T., Ransome, Yusuf, Frasso-Jaramillo, Livia, Moss, Shadiya L., Zhang, Yuehan, Ashing, Kimlin, Denis, Gerald V., Frick, Kevin D., Visvanathan, Kala, Schmitz, Kathryn H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828620/ https://www.ncbi.nlm.nih.gov/pubmed/31446591 http://dx.doi.org/10.1007/s11764-019-00799-1 |
Ejemplares similares
-
“It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema
por: Dean, Lorraine T., et al.
Publicado: (2018) -
Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA
por: Dean, Lorraine T., et al.
Publicado: (2018) -
Patient recommendations for reducing long‐lasting economic burden after breast cancer
por: Dean, Lorraine T., et al.
Publicado: (2019) -
Why individual‐level interventions are not enough: Systems‐level determinants of oral anticancer medication adherence
por: Dean, Lorraine T., et al.
Publicado: (2020) -
Consumer credit, chronic disease and risk behaviours
por: Dean, Lorraine T, et al.
Publicado: (2019)